美国卫生部拟收紧对医药广告的监管，威胁价值100亿美元的市场
特朗普政府的卫生部长罗伯特·肯尼迪正在讨论相关政策，这些政策将使制药公司更难直接向患者进行广告宣传，此举可能会导致每年超过100亿美元的广告支出受到影响。
尽管美国是除新西兰之外唯一一个制药公司可以直接进行广告宣传的国家，但全面禁止制药广告可能会使政府面临法律诉讼的风险，因此政府目前的做法是通过增设法律和财务障碍来减少此类行为的发生，相关消息人士称，他们未获授权公开谈论此事。
医药股盘中全线走低，截至发稿，诺和诺德跌超2%，诺瓦瓦克斯医药跌1.9%，艾伯维公司跌逾1.3%，辉瑞跌0.73%，礼来跌0.85%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10